🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Prostate › Illinois

Qorannoo klinikaalii Kansarii Prostate Illinois keessatti

Qorannoo 64 Kansarii Prostate f Illinois keessatti hirmaatuu jiru.

Magaalota Illinois keessatti

Takkalaa qorannoo (Ingiliffa)

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, Chicago
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05417594

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

  • Jesse Brown VA Medical Center, Chicago, IL, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dhiroota · Haaromfame 05-Onk-2026 · NCT05593497

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University of Chicago Hospital, Chicago
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06465069

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Illinois CancerCare-Bloomington, Bloomington
  • Illinois CancerCare-Canton, Canton
  • Illinois CancerCare-Carthage, Carthage
  • fi 31 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 02-Onk-2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Northwestern University, Chicago
  • Cancer Care Specialists of Illinois - Decatur, Decatur
  • Decatur Memorial Hospital, Decatur
  • fi 8 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 02-Onk-2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Illinois CancerCare-Bloomington, Bloomington
  • Illinois CancerCare-Canton, Canton
  • Carle at The Riverfront, Danville
  • fi 11 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06632977

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • OSF Saint Anthony's Health Center, Alton
  • Rush-Copley Medical Center, Aurora
  • Advocate Outpatient Center - Aurora, Aurora
  • fi 54 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • University of Illinois Cancer Center, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06172478

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Rush MD Anderson Cancer Center, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
  • Carle at The Riverfront, Danville
  • fi 12 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • Northwestern Medicine Chicago Proton Center, Warrenville
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 29-Ful-2026 · NCT01492972

Precision-Based Genomics in Prostate Cancer

  • NorthShore University HealthSystem, Evanston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Dhiroota · Haaromfame 28-Ful-2026 · NCT04706663

DESTINY-PANTUMOUR04

  • Research Site, Decatur
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07124000

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Illinois Cancer Care ( Site 0104), Peoria
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • Associated Urological Specialists - Chicago Ridge, Chicago Ridge
  • Cancer Care Specialists of Illinois, Decatur
  • Cancer Care Specialists of Illinois, O'Fallon
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 24-Ful-2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • University of Chicago, Chicago
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 hanga 100 · Dhiroota · Haaromfame 22-Ful-2026 · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • University of Illinois Chicago, Chicago
  • Cancer Care Specialists of Illinois, Decatur
  • Midwestern Regional Medical Center dba City of Hope Chicago, Zion
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 22-Ful-2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Northwestern University, Chicago
  • University of Illinois Cancer Center at Chicago, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Dhiroota · Haaromfame 22-Ful-2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Chicago
  • Research Site, Chicago Ridge
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 18-Ful-2026 · NCT06952803

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Rush University Medical Center-Hematology and Oncology ( Site 0028), Chicago
  • University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0063), Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 17-Ful-2026 · NCT06925737

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • NorthShore University Health System, Glenbrook Hospital, Glenview
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 11-Ful-2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Alton Memorial Hospital, Alton
  • Advocate Outpatient Center - Aurora, Aurora
  • Advocate Good Shepherd Hospital, Barrington
  • fi 39 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 10-Ful-2026 · NCT05946213

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

  • University of Illinois Hospital & Health Sciences System, Chicago
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dhiroota · Haaromfame 08-Ful-2026 · NCT05800665

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

  • Associated Urological Specialists, Chicago Ridge
  • NorthShore University HealthSystem, Evanston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dhiroota · Haaromfame 03-Ful-2026 · NCT07005154

MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Namoota walitti qabaa jira
Umuriin 18 fi ol · Dhiroota · Haaromfame 01-Ful-2026 · NCT05710380

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

  • University of Chicago Comprehensive Cancer Center, Chicago
  • Endeavor Health, Evanston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dhiroota · Haaromfame 31-Hag-2026 · NCT05726292

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, O'Fallon
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 26-Hag-2026 · NCT07611110

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • University of Chicago, Chicago
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Dhiroota · Haaromfame 20-Hag-2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Alton Memorial Hospital, Alton
  • OSF Saint Anthony's Health Center, Alton
  • Rush-Copley Medical Center, Aurora
  • fi 42 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 19-Hag-2026 · NCT04423211

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • University of Chicago Medical Center, Chicago
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 100 · Dhiroota · Haaromfame 13-Hag-2026 · NCT05519449

PSMA PET Combined With MRI for the Detection of PCa

  • UroPartners,LLC, Chicago
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Dhiroota · Haaromfame 23-Ado-2026 · NCT07052214

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

  • Northwestern University, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dhiroota · Haaromfame 14-Ado-2026 · NCT05691465

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • University of Illinois, Chicago
  • Elmhurst Memorial Hospital, Elmhurst
  • Edward Hospital/Cancer Center, Naperville
  • fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 14-Ado-2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • Illinois Cancer Specialists, Arlington Heights
  • Comprehensive Urologic Care, Lake Barrington
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dhiroota · Haaromfame 09-Ado-2026 · NCT05413421

CARE Tool Study Aim 3

  • Alton Memorial Hospital, Alton
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ado-2026 · NCT07296887

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

  • Northwestern University, Chicago
Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Dhiroota · Haaromfame 02-Ado-2026 · NCT05852041

Integrated Cancer Repository for Cancer Research

  • Rush-Copley Cancer Care Center, Aurora
  • Rush-Copley Healthcare Center, Yorkville
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 19 hanga 110 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT02012699

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • Northwestern Medicine Chicago Proton Center, Warrenville
Namoota walitti qabaa jira
Umuriin 18 fi ol · Dhiroota · Haaromfame 17-Wax-2026 · NCT00969111

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

  • UChicago Medicine Comprehensive Cancer Center, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Dhiroota · Haaromfame 16-Wax-2026 · NCT05790213

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  • University of Illinois at Chicago, Chicago
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
  • University of Chicago, Chicago
  • fi 3 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 21 fi ol · Dhiroota · Haaromfame 22-Cam-2026 · NCT03151629

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.